EDITORIAL
Risk factors for bronchiolitis and asthma, and COVID-19 symptoms in young children
Philippe Eigenmann,
Corresponding Author
Philippe Eigenmann
Department of Women-Children-Teenagers, University Hospital of Geneva, Geneva, Switzerland
Search for more papers by this authorPhilippe Eigenmann,
Corresponding Author
Philippe Eigenmann
Department of Women-Children-Teenagers, University Hospital of Geneva, Geneva, Switzerland
Search for more papers by this authorFirst published: 31 January 2021
REFERENCES
- 1Atanaskovic-Markovic M. What is new in beta-lactam allergy in children? Pediatr Allergy Immunol. 2021; 32: 219-222. [Online ahead of print].
- 2Diaferio L, Chiriac AM, Leoni MC, et al. Skin tests are important in children with β-lactam hypersensitivity, but may be reduced in number. Pediatr Allergy Immunol. 2019; 30: 462-468.
- 3Pouessel G, Winter N, Lejeune S, et al. Oral challenge without skin testing in children with suspected non-severe betalactam hypersensitivity. Pediatr Allergy Immunol. 2019; 30: 488-490.
- 4Foong R-X, Santos AF. Biomarkers of diagnosis and resolution of food allergy. Pediatr Allergy Immunol. 2021; 32: 223-233. [Online ahead of print].
- 5Douglas LC, Leventer-Roberts M, Levinkron O, et al. Elective caesarean section and bronchiolitis hospitalization: A retrospective cohort study. Pediatr Allergy Immunol. 2021; 32: 280-287. [Online ahead of print].
- 6Zhang X, Zhang X, Zhang N, et al. Airway microbiome, host immune response and recurrent wheezing in infants with severe respiratory syncytial virus bronchiolitis. Pediatr Allergy Immunol. 2020; 31: 281-289.
- 7Metzler S, Frei R, Schmaußer-Hechfellner E, et al. Association between antibiotic treatment during pregnancy and infancy and the development of allergic diseases. Pediatr Allergy Immunol. 2019; 30: 423-433.
- 8Engelkes M, Baan EJ, de Ridder MAJ, et al. Incidence, risk factors and re-exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study. Pediatr Allergy Immunol. 2020; 31: 496-505.
- 9Mejias A, Wu B, Tandon N, et al. Risk of childhood wheeze and asthma after respiratory syncytial virus infection in full-term infants. Pediatr Allergy Immunol. 2020; 31: 47-56.
- 10Mitselou N, Hallberg J, Stephansson O, et al. Adverse pregnancy outcomes and risk of later allergic rhinitis—Nationwide Swedish cohort study. Pediatr Allergy Immunol. 2020; 31: 471-479.
- 11Owora AH, Zhang Y. Childhood wheeze trajectory-specific risk factors: A systematic review and meta-analysis. Pediatr Allergy Immunol. 2021; 32: 34-50. [Online ahead of print].
- 12Krautenbacher N, Kabesch M, Horak E, et al. Asthma in farm children is more determined by genetic polymorphisms and in non-farm children by environmental factors. Pediatr Allergy Immunol. 2021; 32: 295-304. [Online ahead of print].
- 13Ojwang V, Nwaru BI, Takkinen H-M, et al. Early exposure to cats, dogs and farm animals and the risk of childhood asthma and allergy. Pediatr Allergy Immunol. 2020; 31: 265-272.
- 14Le TTK, Nguyen DH, Vu ATL, et al. A cross-sectional, population-based study on the prevalence of food allergies among children in two different socio-economic regions of Vietnam. Pediatr Allergy Immunol. 2019; 30: 348-355.
- 15Botha M, Basera W, Facey-Thomas HE, et al. Nutrition and allergic diseases in urban and rural communities from the South African Food Allergy cohort. Pediatr Allergy Immunol. 2019; 30: 511-521.
- 16Matricardi PM, Negro RWD, Nisini R. The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures. Pediatr Allergy Immunol. 2020; 31: 454-470.
- 17Giacomet V, Stracuzzi M, Paradiso L, et al. Defining the clinical phenotype of COVID-19 in children. Pediatr Allergy Immunol. 2020; 31: 82-84.
- 18Brough HA, Kalayci O, Sediva A, et al. Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – The 2020 COVID-19 pandemic: A statement from the EAACI-section on pediatrics. Pediatr Allergy Immunol. 2020; 31: 442-448.
- 19Leung C. The younger the milder clinical course of COVID-19: Even in newborns? Pediatr Allergy Immunol. 2021; 32: 358-362. [Online ahead of print].
- 20Soresina A, Moratto D, Chiarini M, et al. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Pediatr Allergy Immunol. 2020; 31: 565-569.
- 21Castano-Jaramillo LM, Yamazaki-Nakashimada MA, Mendoza SCS, et al. A male infant with COVID-19 in the context of ARPC1B deficiency. Pediatr Allergy Immunol. 2021; 32: 199-201. [Online ahead of print].
